(ENX) Euronext - Ratings and Ratios
Exchange Platform, Listing Venue, Derivatives, Market Data, Post-Trade
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.29% |
| Yield on Cost 5y | 3.95% |
| Yield CAGR 5y | 11.75% |
| Payout Consistency | 97.5% |
| Payout Ratio | 45.7% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 17.5% |
| Value at Risk 5%th | 27.6% |
| Relative Tail Risk | -4.13% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.84 |
| Alpha | 14.69 |
| CAGR/Max DD | 1.11 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.487 |
| Beta | 0.027 |
| Beta Downside | 0.034 |
| Drawdowns 3y | |
|---|---|
| Max DD | 20.42% |
| Mean DD | 5.96% |
| Median DD | 2.83% |
Description: ENX Euronext October 30, 2025
Euronext N.V. (ENX) operates a pan-European network of securities and derivatives exchanges-including venues in the Netherlands, France, Italy, Belgium, Portugal, Ireland, Norway, Denmark, and the United States-plus a suite of ancillary services such as market-data distribution, post-trade clearing, custody, and technology solutions for third-party venues.
The core product set includes cash-equities listings, multilateral trading facilities (MTFs) for equities, fixed-income, and exchange-traded products, as well as options on blue-chip stocks and commodity futures (e.g., milling-wheat contracts). Euronext also monetises real-time, historical, and reference data, and offers colocation, network, and regulatory-reporting services to institutional clients.
Key recent metrics (FY 2023): net revenue €1.47 bn (+5 % YoY), trading volume growth of 3 % across cash equities, and a 7 % increase in data-service subscriptions, reflecting continued demand for low-latency market infrastructure and ESG-focused listings.
Sector drivers that materially affect Euronext’s outlook include: (1) the EU’s MiFID II and upcoming MiFID III reforms, which tighten transparency and could boost data-service revenues; (2) the ongoing consolidation of European exchanges, positioning Euronext as a preferred partner for cross-border listings; and (3) macro-economic trends in the eurozone-particularly GDP growth and corporate earnings-since they directly influence trading activity and new-issue pipelines.
Given the company’s diversified revenue streams and exposure to both traditional equity markets and fast-growing data services, a deeper quantitative assessment (e.g., discounted cash-flow model using the latest earnings guidance) is warranted; you may find ValueRay’s analyst tools useful for that next step.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (642.8m TTM) > 0 and > 6% of Revenue (6% = 106.6m TTM) |
| FCFTA 0.00 (>2.0%) and ΔFCFTA -0.03pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -8806 % (prev 54.33%; Δ -8860 pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.00 (>3.0%) and CFO 928.7m > Net Income 642.8m (YES >=105%, WARN >=100%) |
| Net Debt (1.77b) to EBITDA (1.14b) ratio: 1.55 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.56 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (102.7m) change vs 12m ago -1.50% (target <= -2.0% for YES) |
| Gross Margin 83.52% (prev 55.29%; Δ 28.23pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 0.57% (prev 0.61%; Δ -0.05pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 348.3 (EBITDA TTM 1.14b / Interest Expense TTM 2.72m) >= 6 (WARN >= 3) |
Altman Z'' -2.76
| (A) -0.43 = (Total Current Assets 202.74b - Total Current Liabilities 359.25b) / Total Assets 366.65b |
| (B) 0.01 = Retained Earnings (Balance) 1.84b / Total Assets 366.65b |
| (C) 0.00 = EBIT TTM 946.2m / Avg Total Assets 312.30b |
| (D) 0.01 = Book Value of Equity 2.15b / Total Liabilities 362.20b |
| Total Rating: -2.76 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 80.13
| 1. Piotroski 5.50pt |
| 2. FCF Yield 5.77% |
| 3. FCF Margin 48.14% |
| 4. Debt/Equity 0.70 |
| 5. Debt/Ebitda 1.55 |
| 6. ROIC - WACC (= 4.63)% |
| 7. RoE 15.19% |
| 8. Rev. Trend 75.35% |
| 9. EPS Trend 68.24% |
What is the price of ENX shares?
Over the past week, the price has changed by +0.16%, over one month by -3.58%, over three months by -0.08% and over the past year by +20.59%.
Is ENX a buy, sell or hold?
What are the forecasts/targets for the ENX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 147.7 | 16.7% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 144.3 | 14% |
ENX Fundamental Data Overview December 27, 2025
Market Cap EUR = 13.13b (13.13b EUR * 1.0 EUR.EUR)
P/E Trailing = 19.9685
P/E Forward = 16.1031
P/S = 7.3819
P/B = 3.0529
P/EG = 2.2371
Beta = 0.943
Revenue TTM = 1.78b EUR
EBIT TTM = 946.2m EUR
EBITDA TTM = 1.14b EUR
Long Term Debt = 2.54b EUR (from longTermDebt, last fiscal year)
Short Term Debt = 630.9m EUR (from shortTermDebt, last quarter)
Debt = 3.01b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.77b EUR (from netDebt column, last quarter)
Enterprise Value = 14.83b EUR (13.13b + Debt 3.01b - CCE 1.31b)
Interest Coverage Ratio = 348.3 (Ebit TTM 946.2m / Interest Expense TTM 2.72m)
FCF Yield = 5.77% (FCF TTM 855.6m / Enterprise Value 14.83b)
FCF Margin = 48.14% (FCF TTM 855.6m / Revenue TTM 1.78b)
Net Margin = 36.17% (Net Income TTM 642.8m / Revenue TTM 1.78b)
Gross Margin = 83.52% ((Revenue TTM 1.78b - Cost of Revenue TTM 292.9m) / Revenue TTM)
Gross Margin QoQ = 100.0% (prev 87.58%)
Tobins Q-Ratio = 0.04 (Enterprise Value 14.83b / Total Assets 366.65b)
Interest Expense / Debt = 0.04% (Interest Expense 1.22m / Debt 3.01b)
Taxrate = 26.70% (58.5m / 219.1m)
NOPAT = 693.6m (EBIT 946.2m * (1 - 26.70%))
Current Ratio = 0.56 (Total Current Assets 202.74b / Total Current Liabilities 359.25b)
Debt / Equity = 0.70 (Debt 3.01b / totalStockholderEquity, last quarter 4.30b)
Debt / EBITDA = 1.55 (Net Debt 1.77b / EBITDA 1.14b)
Debt / FCF = 2.07 (Net Debt 1.77b / FCF TTM 855.6m)
Total Stockholder Equity = 4.23b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.18% (Net Income 642.8m / Total Assets 366.65b)
RoE = 15.19% (Net Income TTM 642.8m / Total Stockholder Equity 4.23b)
RoCE = 13.98% (EBIT 946.2m / Capital Employed (Equity 4.23b + L.T.Debt 2.54b))
RoIC = 9.61% (NOPAT 693.6m / Invested Capital 7.22b)
WACC = 4.98% (E(13.13b)/V(16.14b) * Re(6.12%) + D(3.01b)/V(16.14b) * Rd(0.04%) * (1-Tc(0.27)))
Discount Rate = 6.12% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -1.75%
[DCF Debug] Terminal Value 79.86% ; FCFE base≈788.9m ; Y1≈884.3m ; Y5≈1.18b
Fair Price DCF = 197.2 (DCF Value 20.44b / Shares Outstanding 103.7m; 5y FCF grow 14.01% → 3.0% )
EPS Correlation: 68.24 | EPS CAGR: 6.39% | SUE: 0.0 | # QB: 0
Revenue Correlation: 75.35 | Revenue CAGR: 4.97% | SUE: -0.37 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.92 | Chg30d=+0.000 | Revisions Net=-2 | Analysts=3
EPS next Year (2026-12-31): EPS=7.73 | Chg30d=+0.027 | Revisions Net=+1 | Growth EPS=+6.5% | Growth Revenue=+5.3%